The RB-E2F1 Pathway Regulates Autophagy
Open accessPublished version of a preprint
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Autophagy is a protective mechanism that renders cells viable in stressful conditions. Emerging evidence suggests that this cellular process is also a tumor suppressor pathway. Previous studies showed that cyclin-dependent kinase inhibitors (CDKI) induce autophagy. Whether retinoblastoma protein (RB), a key tumor suppressor and downstream target of CDKIs, induces autophagy is not clear. Here, we show that RB triggers autophagy and that the RB activators p16INK4a and p27/kip1 induce autophagy in an RB-dependent manner. RB binding to E2 transcription factor (E2F) is required for autophagy induction and E2F1 antagonizes RB-induced autophagy, leading to apoptosis. Downregulation of E2F1 in cells results in high levels of autophagy. Our findings indicate that RB induces autophagy by repressing E2F1 activity. We speculate that this newly discovered aspect of RB function is relevant to cancer development and therapy. Cancer Res; 70(20); 7882–93. ©2010 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Mitochondrial Autophagy Is an HIF-1-dependent Adaptive Metabolic Response to Hypoxia
Zhang, H., Bosch-Marce, M., Shimoda, L. A., Tan, Y. S., Baek, J. H., Wesley, J. B., Gonzalez, F. J., & Semenza, G. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800102200 · Cited by 1,601 · cited 1×
“On the other hand, RB interacts with more than 200 proteins (6), one of which is the hypoxia-inducible factor, which is a potent inducer of autophagy under hypoxic conditions (51).”
BackgroundRetractedCDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Loss of autophagy in the central nervous system causes neurodegeneration in mice
Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J.-I., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., et al. (2006) · Nature · doi:10.1038/nature04723 · Cited by 3,500 · cited 1×
“Interestingly, Atg7 deficiency in the central nervous system also causes massive neuronal loss in the cerebral and cerebellar cortices (41), suggesting a cross-talk between autophagy and apoptosis (39).”
BackgroundPromotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene
Qu, X., Yu, J., Bhagat, G., Furuya, N., Hibshoosh, H., Troxel, A., Rosen, J., Eskelinen, E.-L., Mizushima, N., Ohsumi, Y., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci20039 · Cited by 2,311 · cited 1×
“Of particular importance, the inactivation of several key autophagy regulators, such as Beclin 1 and ATG4, results in spontaneous tumors (4) or increases the formation of tumors by carcinogens in mice (5).”
BackgroundKimura, S., Noda, T., & Yoshimori, T. (2007) · Autophagy · doi:10.4161/auto.4451 · Cited by 2,278
Mathew, R., Karantza-Wadsworth, V., & White, E. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2254 · Cited by 1,798 · cited 1×
“Moreover, during its growth, the tumor is usually poorly vascularized in the center area, and in this environment, autophagy has a more prominent role in sustaining cell viability in cancer cells (42).”
BackgroundSelf-citationDolma, S., Lessnick, S. L., Hahn, W. C., & Stockwell, B. R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00050-3 · Cited by 1,446
Tor-Mediated Induction of Autophagy via an Apg1 Protein Kinase Complex
Kamada, Y., Funakoshi, T., Shintani, T., Nagano, K., Ohsumi, M., & Ohsumi, Y. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.6.1507 · Cited by 1,145
Autophagy mediates the mitotic senescence transition
Young, A. R. J., Narita, M., Ferreira, M., Kirschner, K., Sadaie, M., Darot, J. F. J., Tavaré, S., Arakawa, S., Shimizu, S., Watt, F. M., et al. (2009) · Genes & Development · doi:10.1101/gad.519709 · Cited by 1,078
The retinoblastoma tumour suppressor in development and cancer
Classon, M., & Harlow, E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc950 · Cited by 738 · cited 4×
“Copyright © 2010 American Association for Cancer Research hypophosphorylation of RB, which is the active form of the protein (6).”
BackgroundInfluential
Research works printed but not linked: 38
- Levine, 2004, Development by self-digestion: molecular mechanisms and biological functions of autophagy, Dev Cell, 6, 463, 10.1016/S1534-5807(04)00099-1 · DOI · Paper page
- Levine, 2008, Autophagy in the pathogenesis of disease, Cell, 132, 27, 10.1016/j.cell.2007.12.018 · DOI · Paper page
- Edinger, 2003, Defective autophagy leads to cancer, Cancer Cell, 4, 422, 10.1016/S1535-6108(03)00306-4 · DOI · Paper page
- Marino, 2007, Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3, J Biol Chem, 282, 18573, 10.1074/jbc.M701194200 · DOI · Paper page
- Stengel, 2008, RB status governs differential sensitivity to cytotoxic and molecularly targeted therapeutic agents, Cell Cycle, 7, 1095, 10.4161/cc.7.8.5737 · DOI
- Knudsen, 2008, Tailoring to RB: tumour suppressor status and therapeutic response, Nat Rev Cancer, 8, 714, 10.1038/nrc2401 · DOI · Paper page
- Grim, 1997, Adenovirus-mediated delivery of p16 to p16-deficient human bladder cancer cells confers chemoresistance to cisplatin and paclitaxel, Clin Cancer Res, 3, 2415
- Komata, 2003, Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIP1) and p27(KIP1)) on malignant glioma cells, Br J Cancer, 88, 1277, 10.1038/sj.bjc.6600862 · DOI
- Liang, 2007, The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis, Nat Cell Biol, 9, 218, 10.1038/ncb1537 · DOI · Paper page
- Hallstrom, 2009, Balancing the decision of cell proliferation and cell fate, Cell Cycle, 8, 532, 10.4161/cc.8.4.7609 · DOI
- Polager, 2008, E2F—at the crossroads of life and death, Trends Cell Biol, 18, 528, 10.1016/j.tcb.2008.08.003 · DOI · Paper page
- Jiang, 2007, Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death, J Natl Cancer Inst, 99, 1410, 10.1093/jnci/djm102 · DOI · Paper page
- Templeton, 1991, Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering, Proc Natl Acad Sci U S A, 88, 3033, 10.1073/pnas.88.8.3033 · DOI · Paper page
- Lohmann, 1994, Distinct RB1 gene mutations with low penetrance in hereditary retinoblastoma, Hum Genet, 94, 349, 10.1007/BF00201591 · DOI
- Fueyo, 1998, Adenovirus-mediated p16 transfer to glioma cells induces G1 arrest and protects from paclitaxel and topotecan: implications for therapy, Int J Oncol, 12, 665
- Jones, 1978, Isolation of deletion and substitution mutants of adenovirus type 5, Cell, 13, 181, 10.1016/0092-8674(78)90148-4 · DOI · Paper page
- Fueyo, 1998, Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo, Nat Med, 4, 685, 10.1038/nm0698-685 · DOI · Paper page
- Rogoff, 2004, Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2, Mol Cell Biol, 24, 2968, 10.1128/MCB.24.7.2968-2977.2004 · DOI · Paper page
- Yang, 2007, Disruption of the retinoblastoma pathway by small interfering RNA and ectopic expression of the catalytic subunit of telomerase lead to immortalization of human ovarian surface epithelial cells, Oncogene, 26, 1492, 10.1038/sj.onc.1209905 · DOI
- Johnson, 1994, Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression, Genes Dev, 8, 1514, 10.1101/gad.8.13.1514 · DOI · Paper page
- Pattingre, 2005, Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy, Cell, 122, 927, 10.1016/j.cell.2005.07.002 · DOI · Paper page
- Gomez-Manzano, 2001, Transfer of E2F-1 to human glioma cells results in transcriptional up-regulation of Bcl-2, Cancer Res, 61, 6693
- Baldassarre, 2005, p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion, Cancer Cell, 7, 51, 10.1016/j.ccr.2004.11.025 · DOI · Paper page
- Besson, 2004, p27Kip1 modulates cell migration through the regulation of RhoA activation, Genes Dev, 18, 862, 10.1101/gad.1185504 · DOI · Paper page
- van den Heuvel, 2008, Conserved functions of the pRB and E2F families, Nat Rev Mol Cell Biol, 9, 713, 10.1038/nrm2469 · DOI · Paper page
- Nevins, 2001, The Rb/E2F pathway and cancer, Hum Mol Genet, 10, 699, 10.1093/hmg/10.7.699 · DOI · Paper page
- Karantza-Wadsworth, 2007, Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis, Genes Dev, 21, 1621, 10.1101/gad.1565707 · DOI · Paper page
- Kisen, 1993, Reduced autophagic activity in primary rat hepatocellular carcinoma and ascites hepatoma cells, Carcinogenesis, 14, 2501, 10.1093/carcin/14.12.2501 · DOI · Paper page
- Gronostajski, 1984, Protein degradation in 3T3 cells and tumorigenic transformed 3T3 cells, J Cell Physiol, 119, 127, 10.1002/jcp.1041190120 · DOI · Paper page
- Knudsen, Targeting the RB-pathway in cancer therapy, Clin Cancer Res, 16, 1094, 10.1158/1078-0432.CCR-09-0787 · DOI · Paper page
- Mizushima, 2008, Autophagy fights disease through cellular self-digestion, Nature, 451, 1069, 10.1038/nature06639 · DOI · Paper page
- Maiuri, 2007, Self-eating and self-killing: crosstalk between autophagy and apoptosis, Nat Rev Mol Cell Biol, 8, 741, 10.1038/nrm2239 · DOI · Paper page
- Lee, 1992, Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis, Nature, 359, 288, 10.1038/359288a0 · DOI · Paper page
- Tomida, 1996, Glucose-regulated stresses cause decreased expression of cyclin D1 and hypophosphorylation of retinoblastoma protein in human cancer cells, Oncogene, 13, 2699
- Mayhew, 2004, Discrete signaling pathways participate in RB-dependent responses to chemotherapeutic agents, Oncogene, 23, 4107, 10.1038/sj.onc.1207503 · DOI
- Weller, 1998, Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses, Int J Cancer, 79, 640, 10.1002/(SICI)1097-0215(19981218)79:6<640::AID-IJC15>3.0.CO;2-Z · DOI · Paper page
- Johnson, 2006, Putting the oncogenic and tumor suppressive activities of E2F into context, Curr Mol Med, 6, 731
- Brown, 1995, Control of p70 s6 kinase by kinase activity of FRAP in vivo, Nature, 377, 441, 10.1038/377441a0 · DOI · Paper page
Cited by
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
Self-citationGuidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1797280 · Cited by 2,897
Self-citationAutophagy in malignant transformation and cancer progression
Galluzzi, L., Pietrocola, F., Bravo‐San Pedro, J. M., Amaravadi, R. K., Baehrecke, E. H., Cecconi, F., Codogno, P., Debnath, J., Gewirtz, D. A., Karantza, V., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490784 · Cited by 1,182
Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases
Hydbring, P., Malumbres, M., & Sicinski, P. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.27 · Cited by 528
Autophagy as a molecular target for cancer treatment
Kocaturk, N. M., Akkoc, Y., Kig, C., Bayraktar, O., Gozuacik, D., & Kutlu, O. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.04.011 · Cited by 387
Metadata
- Authors
- Jiang, H., Martin, V., Gomez-Manzano, C., Johnson, D. G., Alonso, M., White, E., Xu, J., McDonnell, T. J., Shinojima, N., & Fueyo, J.
- Venue
- Cancer Research
- Published
- 2010-10-13
- Volume
- 70
- Issue
- 20
- Pages
- 7882-7893
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2146731647
- Cited by
- 115
- References
- 14
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The RB-E2F1 Pathway Regulates Autophagy. https://app.cochat.ai/papers/10.1158/0008-5472.can-10-1604
- The paper
- Jiang, H., Martin, V., Gomez-Manzano, C., Johnson, D. G., Alonso, M., White, E., Xu, J., McDonnell, T. J., Shinojima, N., & Fueyo, J. (2010). The RB-E2F1 Pathway Regulates Autophagy. Cancer Research. https://doi.org/10.1158/0008-5472.can-10-1604
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.